Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Bayer discovers new MMP inhibitors for arthritic diseases

Aug. 11, 1998

FDA committee recommends approval of Arava for the treatment of rheumatoid arthritis

Aug. 11, 1998

Hoechst describes new compounds for rheumatoid arthritis and allergy

Aug. 11, 1998

Cypress Bioscience files PMA for Prosorba Column

July 28, 1998

Zeneca presents peptides for modifying autoimmune responses as in RA

July 27, 1998

Alexion's C5 inhibitor enters clinic for second autoimmune disorder

July 24, 1998

Dipeptidyl peptidase IV inhibitors developed at Tanabe

July 24, 1998

Antiinflammatory/immunomodulating peptide available for licensing from BTG

July 24, 1998

Daiichi team discloses ICAM-1 production inhibitors for inflammatory disorders

July 23, 1998

Sankyo prepares inhibitors of TNF-alpha production

July 23, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...